All Articles

Northpointe Bancshares leverages innovative mortgage products for impressive growth, but a reliance on costly funding and shrinking margins tests its unique strategy.

Peer-reviewed data confirms Telix's theranostic approach for advanced prostate cancer, de-risking its Phase 3 trial and setting the stage for a new competitor.

A burrito recall over undeclared soy and sausage in a veggie item is just the latest crisis for Fresh & Ready Foods, revealing systemic risks in our food system.

Sigma Foods reports record Q2 earnings, driven by powerhouse performance in Mexico and a key U.S. acquisition. The company’s resilient European turnaround proves its mettle.

As a deadly Ebola outbreak grips Central Africa, OraSure's new 30-minute test offers a critical lifeline, empowering frontline workers without labs or power.

Maintaining its $2.10 annualized distribution, CrossAmerica Partners signals robust operational health ahead of Q2 earnings, offering a stable haven for investors.

Range Resources delivered record operational feats and strong shareholder returns in Q2, showcasing a strategy that leverages Appalachian efficiency for global reach.

As Fuel Tech preps its Q2 results, investors watch closely. Is its advanced environmental tech a niche novelty or the engine for sustainable profitability?

Annaly's strong Q2 results and dividend hike are more than good news; they reveal a disciplined strategy of diversification and risk management paying off.

Bob Ritchie's 'Thought Leader of the Year' award isn't just a trophy. It's a nod to his bold strategy that tamed Florida's chaotic insurance market.

As Boise Cascade prepares its Q2 report, investors and industry leaders are watching closely for signs of how the housing market's crosscurrents are shaping the future.

A new protocol aims to transform passive ETH staking into an active financial tool, connecting it to liquidity and borrowing. But can it succeed?

Evolve's new purpose-built platform for mechanical trades signals a market shift where niche, integrated software is becoming a critical tool for growth.

While headline numbers show a slight dip, Orrstown's Q2 results showcase shrewd balance sheet moves, record fee income, and pristine credit quality.

New preclinical data shows atebimetinib outmaneuvers older drugs by hitting cancer hard, then resting. Is this the key to durable tumor control and resilience?

Capital One's strong Q2 profits signal its major acquisitions are paying off, powered by a unique cloud-first strategy that sets a new industry benchmark.

A 15.5% sales surge and a return to operating income signal a turnaround for the Canadian jeweler, driven by a key acquisition and its own brand's revival.

TrustCo Bank's 12.8% income jump is just the start. A massive stock buyback is supercharging EPS, while a quiet expansion in Florida signals its next move.

A $15.97M federal grant will help Virginia's APM Tech Hub create a fully domestic drug supply chain, tackling critical shortages and boosting US manufacturing.

Gesa Credit Union's acquisition of Willamette Valley Bank signals a major shift, blending a credit union's scale with a community bank's local roots.